title: Alemtuzumab and Multiple Sclerosis: Another Note of Caution.
authors.affiliation: Institute of Clinical Neuroimmunology, Biomedical Center and Klinikum Grosshadern, Munich, Germany2Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
authors.forename: Reinhard
authors.initials: R
authors.lastname: Hohlfeld
authors.affiliation: Institute of Clinical Neuroimmunology, Biomedical Center and Klinikum Grosshadern, Munich, Germany.
authors.forename: Tania
authors.initials: T
authors.lastname: Kümpfel
mesh_terms: D000074323:Alemtuzumab; D006801:Humans; D016899:Interferon-beta; D009103:Multiple Sclerosis; D020529:Multiple Sclerosis, Relapsing-Remitting
chemical_list: D000074323:Alemtuzumab; D016899:Interferon-beta